CIBC Private Wealth Group
MLAB icon

CIBC Private Wealth Group’s Mesa Laboratories MLAB Stock Holding History

CIBC Private Wealth Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$79 Sell
1
-49
-98% -$3.73K ﹤0.01% 3320
2025
Q3 		$3.36K Sell
50
-209
-81% -$15K ﹤0.01% 2644
2025
Q2 		$24.4K Sell
259
-1
-0.4% -$110 ﹤0.01% 1942
2025
Q1 		$27.3K Buy
260
+1
+0.4% +$136 ﹤0.01% 1878
2024
Q4 		$36.7K Buy
259
+1
+0.4% +$123 ﹤0.01% 1796
2024
Q3 		$33.5K Buy
258
+208
+416% +$24.5K ﹤0.01% 1923
2024
Q2 		$4.76K Hold
50
– – ﹤0.01% 2525
2024
Q1 		$5.6K Buy
+50
New +$5.04K ﹤0.01% 2466

Other funds holding MLAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

CIBC Private Wealth Group's MLAB Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Mesa Laboratories (MLAB) stake by 98% in Q4 2025, selling an estimated $3.73K and leaving 1 share worth $79. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

CIBC Private Wealth Group first reported a position in MLAB in Q1 2024 and has held it in 8 quarters since. The position peaked at $36.7K in Q4 2024. 159 funds tracked by Wall St. Rank hold MLAB as of Q4 2025.

  • CIBC Private Wealth Group held 1 share of Mesa Laboratories worth $79 as of Q4 2025.
  • CIBC Private Wealth Group sold 49 Mesa Laboratories shares in Q4 2025, an estimated $3.73K.
  • Mesa Laboratories made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3320 holding.
  • CIBC Private Wealth Group first reported a position in Mesa Laboratories in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Mesa Laboratories position peaked at $36.7K in Q4 2024.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.